History Mission Strategic plan Role The FAMHP also ensures that … Our core business Our organisation Organisation chart Our vision and values Vision and ambition Values Commitments by federal administrations Our stakeholders Partners FAMHP customer charter Partners receiving financial support from the FAMHP The FAMHP and European projects Disclaimer Transparency Social media Conditions for reuse (Creative Commons-0 licence)
17/04/2025 REMINDER - Marketing stop of Depakine (sodium valproate) 300 mg/5 ml syrup: beware of medication errors